drugset / Trial / NCT01190670

A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus

NCT01190670

Phase 1 Completed 40 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The objective of the study is to characterize the effect of multiple doses of ASP015K on the pharmacokinetics of a single oral dose or a single intravenous (IV) dose of tacrolimus.

Timeline

Start
2010-07
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Oral
Subject peficitinib Small molecule Oral

Indications

No indication recorded.